|
|
|
|
|
| Kurzporträt
|
|
| Company Informations: |
|
| Founing Year: |
2006 |
| End of Business Year: |
31th of December |
| Accounting Principle: |
Annual Account according to SWISS GAAP FER, as of 30th June 2008 according IFRS |
| Board of Directors: |
Brysch, Ekkehard - Varel (Germany)
|
| Board of Administration: |
Brysch, Wolfgang - Berlin (Germany)
Bott, Axel - Rorschach (Switzerland)
Stadelmann, Heinz - St. Gallen (Switzerland) |
| |
|
| Market Data: |
|
| Principal: |
CHF 8.000.000,- subdivided in 40.000.000 non-par Stocks |
| Shareholder Structure: |
Athenion AG - 57,88 Percent
Abidopharma Swiss Ltd. - 10,00 Percent
Free Float - 32,12 Percent |
| Applicant: |
Close Brothers Seydler Bank AG |
| German Exchange Listing Partner: |
Close Brothers Seydler Bank AG |
| Designated Sponsor: |
Close Brothers Seydler Bank AG |
|
| Lead Broker: |
Close Brothers Seydler Bank AG |
|
|
|
|
|
|
|